[PE27] Poster Session 27
Other skin diseases 2

[PE27-13] Self-administration of icatibant for the treatment of angioedema attacks: findings from the Icatibant Outcome Survey (IOS)

Marcus Maurer¹, Hilary Longhurst^2,3, Werner Aberer⁴, Laurence Bouillet⁵, Anete Grumach⁶, Jaco Botha⁷, Irmgard Andresen⁷, Giorgio Giannattasio⁷, Teresa Caballero⁸ (1.Charité Universitätsmedizin Berlin, Germany, 2.Addenbrooke's Hospital, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, UK, 3.University College London Hospitals, UK, 4.Medical University of Graz, Austria, 5.National Reference Centre for Angioedema, Grenoble University, France, 6.University Center Health ABC, Brazil, 7.Shire (Takeda Pharmaceutical Company Limited.), Switzerland, 8.Hospital Universitario La Paz, Biomedical Research Network on Rare Diseases (CIBERER, U754), Spain)